NS · Pharmaceuticals

Lupin Ltd (LUPIN)

Pharmaceuticals & Biotechnology

Lupin Ltd (LUPIN) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-04, reported market cap is $1.08T, P/E ratio is 16.96, net margin is 23.7%, dividend yield is 0.51%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LUPIN

Market cap

$1.08T

P/E ratio

16.96

Net margin

23.7%

Dividend yield

0.51%

Lupin Ltd (LUPIN) — FAQ

What is Lupin Ltd's market cap?

Lupin Ltd (LUPIN) has a reported market cap of $1.08T (data as of 2026-07-04).

What is LUPIN's P/E ratio?

The price-to-earnings (P/E) ratio for Lupin Ltd (LUPIN) is 16.96 (data as of 2026-07-04).

Does Lupin Ltd pay a dividend?

Lupin Ltd (LUPIN) shows a reported dividend yield of 0.51%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-04).

What sector is Lupin Ltd in?

Lupin Ltd (LUPIN) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is LUPIN listed on?

LUPIN is listed on NS.

What is Lupin Ltd's net margin?

Lupin Ltd (LUPIN) reports a net margin of 23.7% (data as of 2026-07-04).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)